The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novel Pharmacotherapies and Surgical Procedures for Heart Failure: How To Succeed? Treatment ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by